For the treatment of Selenium-tocopherol deficiency syndrome (white muscle disease) in weanling calves and breeding beef cattle.
LEARN MOREGilvetmab is the first and only immune checkpoint inhibitor developed for the treatment of mast cell tumors (MCTs) and melanomas in dogs.
LEARN MOREFor the prevention and treatment of Selenium-Tocopherol Deficiency (white muscle disease) syndrome in calves.
LEARN MOREIndicated for management of chronic keratoconjunctivitis sicca and chronic superficial keratitis in dogs.
LEARN MORE